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Background: Microarray studies using in vitro cultures of synchronized, blood-stage Plasmodium falciparum malaria
parasites have revealed a ‘just-in-time’ cascade of gene expression with some indication that these transcriptional
patterns remain stable even in the presence of external stressors. However, direct analysis of transcription in
P. falciparum blood-stage parasites obtained from the blood of infected patients suggests that parasite gene
expression may be modulated by factors present in the in vivo environment of the host. The aim of this study was
to examine changes in gene expression of the rodent malaria parasite, Plasmodium yoelii 17X, while varying the
in vivo setting of replication.
Methods: Using P. yoelii 17X parasites replicating in vivo, differential gene expression in parasites isolated from
individual mice, from independent infections, during ascending, peak and descending parasitaemia and in the
presence and absence of host antibody responses was examined using P. yoelii DNA microarrays. A genome-wide
analysis to identify coordinated changes in groups of genes associated with specific biological pathways was a
primary focus, although an analysis of the expression patterns of two multi-gene families in P. yoelii, the yir and
pyst-a families, was also completed.
Results: Across experimental conditions, transcription was surprisingly stable with little evidence for distinct
transcriptional states or for consistent changes in specific pathways. Differential gene expression was greatest when
comparing differences due to parasite load and/or host cell availability. However, the number of differentially
expressed genes was generally low. Of genes that were differentially expressed, many involved biologically diverse
pathways. There was little to no differential expression of members of the yir and pyst-a multigene families that
encode polymorphic proteins associated with the membrane of infected erythrocytes. However, a relatively large
number of these genes were expressed during blood-stage infection regardless of experimental condition.
Conclusions: Taken together, these results indicate that 1) P. yoelii gene expression remains stable in the presence
of a changing host environment, and 2) concurrent expression of a large number of the polymorphic yir and pyst-a
genes, rather than differential expression in response to specific host factors, may in itself limit the effectiveness of
host immune responses.
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Of the four species of Plasmodium that infect humans,
Plasmodium falciparum is most commonly associated
with severe disease and mortality, especially in young
children. Immunity to this species does develop, but
requires repeated exposure over many years [1]. Sequen-
cing and annotation of the P. falciparum genome
revealed ~5,300 genes, many of which are predicted to
encode proteins involved in host cell invasion and im-
mune evasion, but the function of a large proportion
remains unknown [2,3]. A detailed microarray study of
gene expression using blood-stage P. falciparum para-
sites cultured in vitro showed that a large percentage of
the genome is expressed during the asexual stage, and
that there is a surprising ‘continuous cascade’ of gene
expression. Most genes are expressed only once during
the asexual cycle and groups of genes involved in similar
processes are active at the same time [4,5]. This highly
coordinated expression profile implies tightly controlled
regulation, although as relatively few transcription fac-
tors have been identified in Plasmodium, precisely how
gene regulation occurs remains incompletely under-
stood. In these transcriptional studies, in vitro cultured
P. falciparum parasites were tightly synchronized to
evaluate gene expression at distinct points during the life
cycle, and growth conditions were controlled to avoid
introducing unwanted stressors and other confounding
factors.
Transcriptional evaluation using malaria parasites iso-
lated from infected individuals is more technically chal-
lenging and is influenced by the diversity of both host
and parasite, their interaction and the ensuing immune
response. Additional environmental factors such as body
temperature, nutritional status and hormone levels [6]
also vary considerably between individuals and may in-
fluence parasite growth, gene expression and ultimately
disease outcome. In one study, a transcriptional analysis
of ring-stage parasites isolated directly from human sub-
jects revealed distinct transcriptional profiles, thought by
the authors to occur in response to the in vivo environ-
ment and not necessarily detectible using parasites cul-
tured in vitro [7]. There has been some debate as to the
reasons for the observed differences [8]. More such
studies are necessary to fully examine parasite gene
expression patterns in vivo and to determine how
they change in response to host factors and immune
pressures.
The genomes of Plasmodium parasites contain a num-
ber of multi-gene families, including the relatively well-
studied var genes of P. falciparum which encode ~60
antigenic variants of P. falciparum erythrocyte mem-
brane protein-1 (PfEMP-1). PfEMP-1 is expressed on the
surface of the infected red blood cell (iRBC) membrane,
and mediates binding to a variety of host endothelial cellreceptors in tissues such as brain, placenta, lung and
kidney [9]. Interestingly, the var genes appear to be
unique to P. falciparum and possibly the chimpanzee
parasite Plasmodium reichenowi [10,11] and are not
present in other plasmodial species [2,12-15]. However,
the genomes of these species of malarial parasites also
contain multi-gene families thought to encode iRBC sur-
face proteins, although the function of these proteins
remains largely unknown. It is thought that altering ex-
pression of members of a multi-gene family functions as
an immune evasion strategy while maintaining the es-
sential function of the encoded protein. The Plasmo-
dium Interspersed Repeats (PIR) multi-gene family is
one such family that is well conserved in the human
malaria parasite Plasmodium vivax (vir, n = 245), the
monkey parasite Plasmodium knowlesi (kir, n = 68) and
the rodent malaria parasites Plasmodium berghei (bir,
n = 245), Plasmodium chabaudi (cir, n = 135) and Plas-
modium yoelii (yir, n = 838) [12,14-17]. Unlike the clonal
expression of P. falciparum var genes [18,19], many pir
genes are concurrently transcribed during blood-stage
infection [20-22], and in the case of the yir family, this
expression appears relatively stable during a primary in-
fection. Sequencing of the P. yoelii genome revealed an-
other multi-gene family designated pyst-a (n = 140),
which are homologous to P. chabaudi glutamate-rich
proteins and to a single hypothetical protein in P. fal-
ciparum (PF14_0604 [3]), P. vivax (Pvx_117290, [3])
and P. knowlesi (PKH_124210, [3]). The glutamate-rich
proteins of P. chabaudi, such as Pc90 (also known as
Pc(em)93, Pc(em)96 and Pch105/RESA) are thought to
localize to the cytoplasmic face of the RBC membrane
and have been shown to be immunogenic [23-29]. To
date, the function of the PYST-A family of proteins
during blood-stage infection in P. yoelii has not been
studied.
Rodent models of malaria present a unique opportun-
ity to examine patterns of gene expression in vivo, allow-
ing for use of cloned parasite strains replicating in
inbred mice. These conditions may reduce some vari-
ability seen when using clinical isolates of P. falciparum
parasites and are technically much more manageable.
These in vivo model systems also allow for examination
of gene expression at various time points post-infection
and make it possible to manipulate the host immune
system under controlled conditions. In this study, the P.
yoelii 17X murine model was utilized to analyse how
parasite gene expression patterns differ between individ-
ual animals infected with the same cloned parasite and
how expression may change across independent infec-
tions initiated with different parasite populations. Gene
expression at various time points post-infection and in
the presence and absence of host immune pressure was
also analyzed. A genome wide analysis was the primary
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conditions was also examined. Results indicate that P.
yoelii gene expression was remarkably stable supporting
the notion that in vivo, external stressors and environ-
mental factors have limited influence on gene transcrip-
tion in Plasmodium blood-stage parasites.
Methods
Ethics statement
All animal studies were reviewed, approved and con-
ducted in compliance with the Institutional Animal Care
and Use Committee (IACUC) of Drexel University Col-
lege of Medicine (protocol approval ID #18874). This
IACUC operates with Public Health Service approval
(Animal Welfare Assurance Number: A-322-01).
Mice and parasites
Five to six week old male BALB/cByJ mice were pur-
chased from The Jackson Laboratory (Bar Harbor,
Maine, USA). Male BALB/cJ and B-cell-deficient JHD
mice [30] on a BALB/cJ background were purchased
from Taconic Farms Inc. (Germantown, NY, USA). All
animals were housed in the Animal Care Facility of
Drexel University College of Medicine under specific
pathogen-free conditions. Food and water were provided
ad libitum and the room was maintained on a 12-hour
light–dark cycle. The lethal and non-lethal 17XL and
17X strains of P. yoelii were originally obtained from Dr
William P Weidanz (University of Wisconsin, Madison,
WI, USA) and maintained as cryopreserved stabilates.
Blood from P. yoelii-infected mice contains a mixture of
ring, trophozoite and schizont stage parasites as replica-
tion is asynchronous. During infection with these P. yoelii
lines, gametocytes are not observed and parasitized blood
is not infective for mosquitoes.
To establish cloned lines of P. yoelii 17X, groups of
three to four male BALB/cByJ mice were infected i.v.
with 25, 10 or one P. yoelii 17X iRBC(s). Blood parasit-
aemia was monitored by the enumeration of parasitized
erythrocytes in thin tail-blood smears stained with
Giemsa (EMD Chemicals, Inc., Gibbstown, NJ, USA).
Parasites from the lowest infective dose were selected as
clones.
PyRMP preparation and generation of anti-PyRMP sera
Male BALB/cByJ mice were infected with 1x106 P. yoelii
17X iRBCs and blood was obtained when parasitaemia
was ~30%. Infected RBCs were separated from unin-
fected RBCs by density gradient centrifugation on a 70%
Percoll gradient (GE Healthcare, Uppsala, Sweden).
Recovered iRBCs were treated with PBS-0.05% saponin
and erythrocyte membranes were separated from intact
parasites by differential centrifugation. Membranes from
uninfected RBCs were also isolated as a control. Proteinconcentrations were determined using the bicinchoninic
acid protein assay (Pierce Chemical Company, Rockford,
IL, USA). The P. yoelii reticulocyte membrane protein
(PyRMP) fraction, uninfected membrane proteins and
parasite-associated antigen were separated by SDS-
PAGE (15 μg/lane) on a 10% polyacrylamide gel and
stained with Coomassie Blue. For the generation of poly-
clonal anti-PyRMP sera, mice were immunized subcuta-
neously three times at three-week intervals with 50 μg/
dose of the PyRMP preparation formulated with 25 μg
Quil A adjuvant (Accurate Chemical and Scientific Cor-
poration, Westbury, NY, USA). Two weeks following the
third immunization, sera was collected.
Immunoblot analysis
The PyRMP fraction, uninfected membrane proteins and
parasite-associated antigen were separated by SDS-PAGE
as above and electroblotted onto nitrocellulose mem-
branes. Membranes were then blocked with 5% (w/v)
non-fat milk in TBS (25 mM Tris–HCl, pH 8.0, 150 mM
NaCl) and probed with normal rabbit serum (1:20,000),
polyclonal rabbit antiserum raised against recombinant
P. yoelii MSP-8 (1:20,000), normal mouse serum (1:1000),
or mouse anti-PyRMP (1:1000) diluted in TBS containing
0.1% (v/v) Tween 20 and 1% (w/v) BSA. Bound antibodies
were detected by chemiluminescence using horseradish
peroxidase conjugated protein A (Pierce Chemical Com-
pany) or rabbit anti-mouse IgG (Invitrogen, Carlsbad,
CA, USA) and the SuperSignal West Pico Substrate
(Pierce Chemical Company).
Indirect-immunofluorescence assay
Blood was collected from P. yoelii 17X infected mice,
washed and resuspended at ~25% haematocrit in PBS
containing 1% (w/v) gelatin. Thin blood films were pre-
pared, air dried and fixed in acetone:methanol (1:1) for
20 min at −20°C. Fixed smears were incubated for
30 min at 37°C in a humidified chamber with anti-
PyRMP sera or normal mouse sera diluted 1:200 in PBS.
Bound antibody was detected using tetramethyl rhoda-
mine (TRITC)-conjugated goat anti-mouse immuno-
globulin G (IgG) (Invitrogen) diluted 1:250 in PBS.
Slides were stained with Hoechst 33258 diluted 1:47,000
in 1X PBS, washed, and mounted with AntiFade reagent
(Invitrogen Molecular Probes, Eugene OR, USA). Images
(1,000X magnification) were obtained using an Olympus
BX60 fluorescent microscope (Olympus America Inc.,
Melville, NY, USA) and a SPOT RT Slider Digital Cam-
era System (Diagnostic Instruments, Sterling Heights,
MI, USA).
Immunizations and infections
Normal and immunodeficient naïve mice were infected
by intraperitoneal injection of 1x105 P. yoelii 17X
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obtained early in infection when parasitaemia was ~15%
(day 10–11), at peak parasitaemia (~35-40%, day 14) or
during descending parasitaemia (~15%, day 18). Alterna-
tively, mice were immunized subcutaneously three times
at three week intervals with 50 μg of the PyRMP fraction
formulated with 25 μg of Quil A adjuvant. Control
groups received Quil A alone. Two weeks following the
final immunization, animals were challenged with 1x105
P. yoelii 17X iRBCs. Infected RBCs for RNA isolation
were obtained from PyRMP-immunized and adjuvant
control mice on day 10–12 of infection.
Plasmodium yoelii DNA microarrays
Plasmodium yoelii DNA microarrays were produced in
the Molecular Genomics Core Facility, Drexel University
College of Medicine, under the direction of LWB. Each
array contained 65-base oligonucleotides, spotted in du-
plicate, representing ~6,700 coding regions predicted
from the P. yoelii genome sequence analysis [12] and
present in the current PlasmoDB and NCBI databases.
Each quadrant of an array contained a pool of P. yoelii
oligos (~2200), spotted in triplicate, which served as a
positive control. Blood from P. yoelii-infected mice was
obtained from individual animals or pooled from groups
of animals (five to 10) as needed. Infected RBCs were
isolated as above by Percoll density gradient centrifuga-
tion. Infected RBCs were saponin lysed and pelleted P.
yoelii parasites were resuspended directly in the TRIzol
Reagent (Invitrogen). Total RNA was extracted, precipi-
tated and purified using an RNeasy RNA isolation kit
(Qiagen, Inc., Valencia, CA, USA).
For all microarrays, gene expression in P. yoelii 17X
blood-stage parasites was evaluated relative to a standard
comparator of purified P. yoelii 17XL total RNA. P. yoelii
RNA (5 μg/sample) was amplified in the presence of
aminoallyl-dUTP using the Amino Allyl MessageAmp II
aRNA amplification kit (Ambion, Inc., Austin, TX,
USA). aRNA was then fluorescently labelled by reaction
with monofunctional, NHS-activated Cy3 or Cy5 dyes
(Amersham Biosciences Inc., Piscataway, NJ, USA). Cy
dye labelled aRNA was purified with yield and specific
activity of each probe determined by absorption spec-
troscopy. Pairs of Cy3 and Cy5 labelled aRNA probes
(1 μg/probe) were pooled, fragmented (Ambion RNA
Fragmentation Reagent) and hybridized to the P. yoelii
microarrays for 14–16 hours at 65°C. Following
hybridization and washing, slides were scanned using a
GenePix 4000A microarray laser scanner (Axon Instru-
ments, Inc., Union City, CA, USA) and the fluorescence
intensity of each DNA feature was determined at
532 nm (Cy3) and 635 nm (Cy5). Data for each gene
was obtained from replicate features on each array. In
addition, replicate arrays and standard dye flips werealso hybridized for each comparison. Fluorescence data
were acquired and initially analysed using GenePixPro
5.1 Software (Axon Instruments, Inc.). Irregular and
missing features flagged during image acquisition, fea-
tures with a diameter of ≤60 μm and features with a sig-
nal to noise ratio (SNR) of <2 on the 532 nm channel
and SNR <2 on the 635 nm channel were removed from
the analysis.
Data analysis
In order to evaluate differential gene expression in P.
yoelii 17X parasites replicating in various in vivo envir-
onments, Cy3 and Cy5 fluorescence intensity data were
processed and analysed using limma version 2.18.2
[31,32] through limmaGUI version 1.20.0 [33] in the R
programming environment [34] The normexp method
with an offset value of 16 was utilized for background
correction [35,36]. Data were normalized using the
print-tip loess method [37]. After fit of a linear model
to the expression data, genes differentially expressed by
at least two-fold were identified (log2-fold change >1
or <−1). Such changes in gene expression were consid-
ered significant based on a p-value ≤ 0.01 obtained from
the moderated t-statistic and adjusted for multiple test-
ing using the method of Benjamini and Hochberg [38].
The false discovery rate was 1%. An initial data analysis
revealed relatively small numbers of differentially
expressed genes across conditions. As such, the final
statistical analysis was completed by multiple pairwise
comparisons of groups, accepting the increased possi-
bility of a type I error - erroneously detecting differ-
ences in gene expression.
The number of yir and pyst-a genes expressed in a
given population of P. yoelii 17X parasites was estimated
based on normalized signal intensity relative to the en-
tire P. yoelii gene set. Fluorescence data were captured
and filtered as described above and analysed using the
Acuity 3.1 Microarray Informatics Software package
(Axon instruments, Inc). On each array, Cy3 and Cy5
signal intensities were normalized such that the ratio of
the median fluorescence intensity of 192 positive control
features equalled 1. A normalized fluorescence intensity
for all genes was calculated by setting the fluorescence
intensity of the positive control to 3,000. Mean fluores-
cence intensity (MFI) was then calculated for each gene
across an array set (i.e., replicate arrays, dye swaps)
and percentiled. Based on mapping data available
through PlasmoDB, 464/859 yir gene oligos and 74/140
pyst-a gene oligos on the arrays detect unique tran-
scripts (Additional file 1). Non-discriminating yir and
pyst-a oligos were eliminated from the analysis. Expres-
sion of ‘unique’ genes was categorized as below detec-
tion (0-50th percentile), low (51-75th percentile),
moderate (76-90th percentile) or high (>90th percentile).
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In an attempt to determine if the expression of genes
involved in similar processes changes in a coordinated
manner in response to the in vivo environment, P. yoelii
genes were grouped into several categories. Bioinfor-
matic data available from the sequencing and annotation
of the P. yoelii genome were considered. As this data set
is incomplete, a substantial set of data available on
orthologs of P. yoelii genes present in the genomes of P.
falciparum, P. vivax, P. knowlesi, P. berghei and P. cha-
baudi were consulted [3]. Likewise, published compara-
tive genomic data and in depth transcriptional profiling
data were also considered. These included the analysis of
the P. falciparum transcriptome of in vitro cultured P.
falciparum blood-stage parasites [4], the analysis of
changes in P. falciparum gene expression in cultured
blood-stage parasites upon exposure to various chemical
compounds [39] and genome-wide comparisons of P.
yoelii, P. berghei and P. chabaudi [40]. Using these
resources, differentially expressed P. yoelii genes were
grouped into three broad categories: i) genes conserved
across malarial species; ii) genes specific to the rodent
malarial parasites; and iii) genes that appear to be
unique to P. yoelii. Within these broad categories, differ-
entially expressed genes were assigned to 16 subcategor-
ies (see Figure 1 and Additional file 2). The evaluation
of genes encoding mitochondria-associated proteins
(Additional file 3) included the set of P. yoelii orthologs
of putative P. falciparum mitochondrial proteins [7,41]
(Mather and Vaidya, unpublished data) for which signal
intensity across arrays was consistently above the 50th
percentile.
Data deposition
The microarray data reported in this paper have been
deposited in the Gene Expression Omnibus database
(GEO) (accession no. GSE31274) [42]. Deposited data
are MIAME compliant [43,44].
Results
Little variation in gene expression in Plasmodium yoelii
17X blood-stage parasites obtained from individual mice
challenged with the same inoculum of iRBCs
In the P. yoelii 17X model, peak parasitaemia generally
occurs on day 14–16, reaching parasitaemias of 40-45% in
BALB/c mice. During this time, the primary immune re-
sponse that ultimately leads to parasite clearance develops.
The percentage of reticulocytes peaks at ~70% slightly
later post-infection (days 16–18). Parasites are generally
cleared from the circulation by day 22–25 post-infection
(Figure 2). As a starting point in evaluating variability in
gene expression in blood-stage parasites replicating
in vivo in different hosts, three mice were simultaneously
infected with 1x105 P. yoelii 17X iRBCs from a singledonor mouse. Parasite diversity was minimized by using a
cloned P. yoelii 17X line. Host diversity was minimized by
using age-matched, male, inbred BALB/cByJ mice housed
together. Parasite RNA was isolated early during infection
when parasitaemia was ascending as follows: mouse 1 -
day 11 at 13.0% parasitaemia; mouse 2 - day 10 at 11.1%
parasitaemia; mouse 3 - day 10 at 18.6% parasitaemia.
Using P. yoelii DNA microarrays (~6,700 oligos), gene ex-
pression profiles were then compared between individual
mice with three pair-wise comparisons (M1/M2, M2/M3
and M1/M3). In all comparisons, a change in expression
of at least two-fold (p ≤0.01) was considered significant.
As shown in Figure 1 and Additional file 2, gene expres-
sion profiles between individual mice were remarkably
consistent. There were no differentially expressed genes
between mouse 1 and mouse 2. Only one gene, mero-
zoite surface protein-1 (MSP1), was down-regulated
~2.3-fold in mouse 3 relative to mouse 2. There were
only five genes differentially expressed when compar-
ing mouse 1 and mouse 3 which included MSP1, two
rhoptry proteins and two proteins with unknown
function. As such, there were minimal differences in
gene expression profiles of P. yoelii 17X parasites
isolated from three separate hosts after a 10–11day
period of replication in vivo.
In the above analysis, no members of the yir or pyst-a
multigene families were differentially expressed between
individual animals. To estimate the number of yir and
pyst-a genes expressed in each population of P. yoelii
17X parasites, signal intensity on each set of arrays was
normalized and percentiled relative to the entire P. yoelii
gene set (Figure 3A). Focusing the analysis on a set of
464 yir gene oligos that could detect unique transcripts,
expression (>50th percentile) of a relatively large number
of yir genes (105, 117, 143) was measurable in parasites
isolated from the three individual mice (Figure 3B).
Combined, 20–40 of these were considered to be
expressed at moderate (76-90th percentile) or high
(>90th percentile) levels. Likewise, based on data
obtained with a subset of 74 unique oligos, expres-
sion (>50th percentile) of multiple pyst-a genes (34,
35, 38) was observed in the three populations of P.
yoelii 17X parasites, with 16–18 detected at moderate
to high levels (Figure 3C). Differences in the number
of ‘expressed’ yir and pyst-a genes in each group are
due to a small number of genes whose signal inten-
sity was near the threshold set for detection (50th
percentile) but where fold-change was less than two
and/or not statistically significant.
Differential gene expression in Plasmodium yoelii 17X
blood-stage parasites marginally increases over time
To determine if P. yoelii gene expression profiles
changed significantly over time in vivo, the patterns of
Figure 1 There is little differential gene expression between
Plasmodium yoelii 17X parasites isolated from individual mice.
Three animals (M1, M2 and M3) were infected with P. yoelii 17X
iRBCs from a single donor mouse. RNA was isolated on day 10 or
11 post-infection and transcripts detected using P. yoelii DNA
microarrays. The three possible pair-wise comparisons are listed at
the top of the figure and functional categories are listed in the far
left column. Solid dark blue boxes indicate that there are no
differentially expressed genes for a given comparison in a particular
functional group. In cases where there are differentially expressed
genes, the number of genes that are up-regulated is listed at the
top half of the box; the number of down-regulated genes is listed in
the bottom half of the box. Up- and down- regulation is reported
with respect to the second animal listed in the column heading. For
example, there is one gene down-regulated in the ‘schizont,
merozoite, invasion’ category in mouse 3 with respect to mouse 2.
The total number of genes that were up- or down-regulated is
indicated at the bottom of the Figure.
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Figure 1 above (day 10–11) were compared to that of
the population of P. yoelii 17X parasites isolated from
the donor animal used to initiate infection on day 0. The
donor mouse was infected using cryopreserved P. yoelii
17X iRBCs. On day 11 of infection in this donor mouse
when parasitaemia was 18.7%, P. yoelii 17X iRBCs were
isolated for infection of M1, M2 and M3 and for RNA
isolation. As shown in Figure 4 and Additional file 4,
some variation in expression profiles was noted in three
pair-wise comparisons between the donor (D) and each
infected mouse (M1, M2, M3). Overall however, the
number of differentially expressed genes remainedFigure 2 Course of Plasmodium yoelii 17X blood stage infection
in male BALB/cByJ mice. Animals (n = 5) were infected by
intraperitoneal injection with 1x105 P. yoelii 17X infected RBCs.
Parasitaemia and percent reticulocytes were monitored in thin
tail-blood smears stained with Giemsa. Average percent parasitaemia
(red) and reticulocytes (blue) at various days post-infection
are shown.
Figure 3 Plasmodium yoelii 17X blood-stage parasites express a large number of yir and pyst-a during infection. Animals were infected
with P. yoelii 17X iRBCs and parasite RNA was collected under various experimental conditions (see Methods). P. yoelii DNA microarrays were
completed and a normalized mean fluorescence intensity for all genes spotted on the P. yoelii array was calculated and percentiled (A). Number
of yir (B) and pyst-a (C) genes in the listed percentile ranges were calculated considering a set of 464 yir gene oligos and 74 pyst-a oligos that
could detect unique transcripts. The number of yir or pyst-a genes expressed (i.e., those with a mean fluorescence intensity above the 50th
percentile) is listed at the top of the Figure above each experimental condition.
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Figure 4 Modest increase in differential gene expression over
the course of a primary Plasmodium yoelii 17X infection. Three
animals (M1, M2 and M3) were infected with P. yoelii 17X iRBCs
from a single donor mouse (D). RNA was isolated on day 10 or
11 post-infection and P. yoelii DNA microarrays were completed. The
three pair-wise comparisons between individual mice and the donor
are listed at the top of the Figure, and functional categories are
listed in the far left column. Up- and down-regulation for each
comparison is indicated as described for Figure 1.
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genes was significantly altered in M1, M2 and M3 rela-
tive to the donor mouse, respectively. The magnitude of
the changes ranged from 2 to 5.8-fold. Genes associated
with schizont rupture and/or merozoite invasion of
RBCs were consistently up-regulated in mouse 1, 2 and
3 relative to the donor animal, and included P. yoelii
orthologs of several rhoptry proteins, MSP1, MyoA,
MTIP, SERA and subtilisin-like protease 2. Similar to
the comparisons between individual mice, expression of
a fairly large number of the yir (95/464) and pyst-a
(34/74) genes was detected above background (>50th
percentile) in the donor mouse (Figure 3). Changes in
yir and pyst-a gene expression from day 0 in the donor
mouse to day 10–11 in the three infected mice were
not remarkable.
Gene expression profiles in Plasmodium yoelii 17X
blood-stage parasites remain relatively stable in
independently infected mice
Given the relatively few differences noted between
donor and individual infected mice, it was of interest
to examine variability in P. yoelii 17X gene expression
across independently initiated infections (I1, I2, I3, I4)
in animals housed separately in time and space. On
four separate occasions, blood from a donor mouse
was used to infect groups of BALB/cByJ mice (n=10).
For each infection, blood from P. yoelii 17X infected
mice was obtained and pooled on days 10–11 of in-
fection when parasitaemia was ascending and was
~15%. P. yoelii 17X RNA from these four independ-
ent infections permitted six pair-wise comparisons.
Gene expression profiles varied to a greater
degree between these independently initiated infec-
tions (Figure 5 and Additional file 5) than between
individual animals concurrently infected with the
same inoculum of P. yoelii 17X iRBCs (Figure 1 and
Additional file 2). Nevertheless, differences were again
lower than expected with the number of genes differ-
entially expressed between any two infections ranging
from only 9 to 56 genes. In each case, at least 40% of
differentially expressed genes are predicted to encode
proteins of unknown function. The remaining genes
in each set were associated with multiple and diverse
Figure 5 Differential gene expression is lower than expected in parasites from independent Plasmodium yoelii 17X infections. Groups
of animals (n = 5-10) were infected on four separate occasions (I1, I2, I3 and I4) using four separate donor animals. RNA was isolated and
transcripts detected using P. yoelii DNA microarrays. The six possible pair-wise comparisons are listed at the top of the Figure and functional
categories are listed in the far left column. Up- and down-regulation for each comparison is indicated as described for Figure 1.
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each population of P. yoelii 17X blood-stage parasites
expressed a relatively large number of yir genes (105
to 138) and pyst-a genes (32 to 39) over background
(>50th percentile) (Figure 3).Plasmodium yoelii gene expression is influenced by
parasitaemia and/or reticulocyte levels
Thus far, P. yoelii gene expression was measured early dur-
ing acute infection and at consistent parasitaemia. How-
ever, P. yoelii 17X preferentially invades reticulocytes and
Figure 6 Parasitaemia and/or host cell availability influence
differential gene expression of Plasmodium yoelii 17X parasites.
Groups of wild-type animals (n=5-10) were infected with P. yoelii 17X
iRBCs and parasite RNA was isolated on day 10, day 14 or day 18
post-infection. Immunologically intact (WT) and B-cell deficient JHD
animals were similarly infected and parasite RNA was isolated on
day 10. A third set of mice was immunized three times with a
preparation of P. yoelii reticulocyte membrane proteins (PyRMP) plus
QuilA as adjuvant (RMP) or with Quil A alone (QA) prior to P. yoelii
challenge. Parasite RNA was isolated on day 10 (QA) or day 12 (RMP)
post-infection. The number of genes up- or down-regulated for a
given comparison and category is listed as described in Figure 1.
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in circulation is low (~15-20%). A sharp increase in
erythropoiesis leads to a marked influx of new reticulocytes
into peripheral circulation and a concurrent rise in P. yoelii
17X parasitaemia. It was of interest to determine if changes
in parasite load and permissive host cell availability affected
P. yoelii gene expression in vivo. P. yoelii 17X iRBCs from
a single donor mouse were used to infect a set of BALB/
cByJ mice. RNA was isolated from P. yoelii iRBCs har-
vested on day 10 (14% parasitaemia, 14.4% reticulocytes)
and on day 14 (43.5% parasitaemia, 57.9% reticulocytes) of
infection. Comparing P. yoelii 17X gene expression pro-
files, there were 15 genes significantly up-regulated
and 75 genes significantly down-regulated on day 14
relative to day 10 (Figure 6 and Additional file 6).
Overall, the magnitude of the changes in gene ex-
pression was again modest varying only 2 to 5.7-fold.
Putative protein functions appeared to be diverse,
with genes encoding proteins of unknown function
being the most commonly represented group. These
tended to be down-regulated on day 14 relative to
day 10. In addition and despite an overall increase in
the number of differentially expressed genes, the ex-
pression of yir and pyst-a gene families remained
relatively constant (Figures 3 and 6).
To further evaluate changes in parasite gene expression
during the course of infection, P. yoelii 17X RNA was iso-
lated on day 10 (19% parasitaemia, 18.6% reticulocytes) and
on day 18 (14% parasitaemia, 70.2% reticulocytes). Al-
though parasite load is similar at these time points, parasit-
aemia is ascending on day 10 and target host cells are
relatively scarce. By day 18 post-infection, parasitaemia is
declining due to immune-mediated mechanisms and reti-
culocytes are abundant. Comparing day 10 and day 18,
there were 192 differentially expressed P. yoelii genes, in-
cluding 67 genes of unknown function (Figure 6 and
Additional file 6). Of those differentially expressed, 94
were up-regulated and 98 were down-regulated on day 18
versus day 10. This set of differentially expressed genes
represents the most variable expression seen across all ex-
perimental conditions. Of interest, genes encoding pro-
teins associated with the cytoplasmic translation
machinery tended to be down-regulated on day 18
(n=11) versus day 10, and included several ribosomal
proteins. In addition, a small set of genes (n=24) encod-
ing proteins involved with schizont rupture and/or mero-
zoite invasion of RBCs tended to be up-regulated on day
18 and these included glidosome- and rhoptry-associated
genes, MSP1 and MSP7. Finally, there were 17 genes en-
coding apicoplast/mitochondrion-associated proteins that
were differentially expressed, with up and down-regulated
genes equally represented. As before, members the yir
and pyst-a multigene families were not differentially
expressed while the number of genes in each family
Figure 7 Membrane preparations from Plasmodium
yoelii-infected RBCs contain unique parasite proteins. Animals
were infected with P. yoelii 17X and infected RBCs were collected.
(A). Proteins associated with the membranes of uninfected (lane 1)
or P. yoelii 17X infected erythrocytes (lane 2) or with intracellular
P. yoelii 17X parasites (lane 3) were separated by SDS-PAGE and
stained with Coomassie Blue. (B). To evaluate the ability to separate
the PyRMPs from parasite associated proteins, isolated protein
fractions were separated as in A, blotted onto nitrocellulose and
probed with rabbit anti-mouse PyMSP8 polyclonal sera. PyMSP8 is a
GPI-anchored membrane protein of P. yoelii trophozoites and
merozoites. Normal rabbit sera (NRS) served as a negative control.
Molecular weights in kiloDaltons (kDa) are indicated.
Figure 8 Immunization induces antibody responses to proteins
associated with the PyRMP fraction. Animals were immunized
three times with the PyRMP preparation and sera were collected.
Proteins associated with the membrane of uninfected RBCs (lane 1)
or P. yoelii 17X infected RBCs (lane 2) were separated by SDS-PAGE,
immunoblotted and probed with a pool of PyRMP antisera. Normal
mouse sera (NMS) served as a negative control. Molecular weights in
kiloDaltons (kDa) are indicated.
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genes, 37 pyst-a genes).
Changes in immune pressure do not significantly alter
Plasmodium yoelii 17X gene expression during
a primary infection
To specifically evaluate whether the presence or absence
of host immune pressure affects parasite gene expression
in vivo, two experimental approaches were taken. In the
first approach, all antibody-dependent immune pressure
was removed by use of B cell deficient mice. Naïve, im-
munocompetent BALB/c mice and B cell deficient, JHD
mice on a BALB/c background were concurrently
infected with P. yoelii 17X iRBCs obtained from the
same donor animal. P. yoelii gene expression in the two
hosts was evaluated when ascending parasitaemia
reached ~15%. Surprisingly, changes in gene expression
were negligible with only seven differentially expressed
genes, five of which were of unknown function (Figure 6
and Additional file 6). No yir or pyst-a genes were differ-
entially expressed between the populations of P. yoelii
17X parasites.
In a second approach, antibody-mediated immune
pressure was applied by immunizing animals with a
preparation of membrane proteins isolated from P. yoelii
17X infected reticulocytes (P. yoelii reticulocyte mem-
brane proteins, PyRMPs). SDS-PAGE and Coomassie-
blue staining of proteins associated with the membranes
of uninfected versus P. yoelii 17X infected RBCs revealed
several protein bands unique to the PyRMP fraction(Figure 7A, lanes 1 & 2). Immunoblot analysis to assess
separation of reticulocyte membrane proteins from para-
site membrane proteins showed that the GPI-anchored
merozoite surface protein 8 was present in parasite but
not reticulocyte membrane fractions (Figure 7B). Anti-
bodies from mice immunized with the PyRMP prepar-
ation recognized 8–10 distinct polypeptides present in
the PyRMP fraction (Figure 8). In indirect immunofluor-
escence assays, these antibodies specifically stained pro-
teins localized to both the intracellular parasite and the
iRBC membrane (Figure 9). To determine if the pres-
ence of PyRMP-specific antibodies affected parasite
growth and gene expression, PyRMP immunized and ad-
juvant control (Quil A) mice were challenged with P.
yoelii 17X iRBCs from the same donor mouse. To some
degree, PyRMP immunization limited parasite replica-
tion early during infection but over time these animals
developed relatively high and persistent parasitaemia
and were sacrificed (Figure 10). To determine if the
presence of anti-PyRMP antibodies influenced patterns
of gene expression, RNA was isolated from P. yoelii 17X
parasites on day 10 from Quil A control mice (15.6%
parasitaemia) or day 12 from PyRMP immunized mice
(13.3% parasitaemia) post-infection and subjected to
microarray analysis (Figure 6 and Additional file 6).
Similar to the results in JHD mice in the absence of anti-
body responses, increasing immune pressure by PyRMP
immunization led to negligible differences in gene ex-
pression. Comparison of expression profiles of P. yoelii
Figure 9 Anti-PyRMP antibodies detect Plasmodium yoelii
proteins associated with the intracellular parasite and the
reticulocyte membrane. Immunofluorescence of P. yoelii 17X
infected reticulocytes using polyclonal PyRMP sera or normal mouse
sera. Row A: Differential interference contrast images; Row B: Parasite
DNA stained with DAPI (blue); Row C: Localization of P. yoelii
proteins recognized by anti-PyRMP sera (TRITC, red). Background
staining with normal mouse sera (NMS) is shown.
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nized mice revealed only 10 differentially expressed genes
including three with no known function. Unexpectedly,
no members of the yir or pyst-a multi-gene families were
differentially expressed. Consistent with the earlier data
however, expression (>50th percentile) of 134 yir genesFigure 10 Course of Plasmodium yoelii 17X infection following
PyRMP immunization. Animals (n = 5) were immunized three times
with the PyRMP preparation plus Quil A adjuvant. A separate group
of animals received Quil A alone. Both groups were challenged with
1x105 P. yoelii 17X iRBCs intraperitoneally. Parasitaemia was
monitored in thin tail-blood smears stained with Giemsa at various
time points post-infection. ‘#d’ indicates the number of animals at
each time point that were sacrificed due to high parasitaemia
and/or significant anemia.and 36 pyst-a genes in Quil A control mice and 143 yir
genes and 36 genes pyst-a in PyRMP immunized mice
was detected (Figure 3, Inf. #1 & PyRMP). Combined, the
data indicate that in vivo, P. yoelii 17X gene expression
was only minimally altered by increasing or decreasing
antibody-mediated immune pressure.
Discussion
Transcription in P. falciparum and P. vivax parasites
appears to be tightly regulated, resulting in a ‘continuous
cascade’ of gene expression during blood-stage develop-
ment [4,5,45]. There is some evidence that this tran-
scriptional programme continues unabated even in the
presence of external stresses. In one study, anti-folate
treatment of cultures of drug-sensitive P. falciparum
blood-stage parasites did not lead to increased expres-
sion of the defined drug target, dihydrofolate reductase-
thymidylate synthatase. Additionally, there were no
genes differentially regulated greater than two-fold be-
tween control and drug treated cultures [46]. Similarly,
Gunasekera et al. [47] found little variation in transcrip-
tion patterns between untreated and chloroquine-treated
P. falciparum parasites growing asynchronously in cul-
ture. These results were unexpected, as genome-wide
studies in organisms such as Saccharomyces cerevisiae,
Mycobacterium tuberculosis and Candida albicans
revealed differential expression of hundreds of genes in
response to drug treatment, and these changes often
confirmed or revealed associated drug targets and
affected pathways [48-51]. However, other studies in
Plasmodium examining the effects of drug treatment or
manipulation of culture conditions have found more
substantial transcriptional changes (~300-400 differen-
tially expressed genes), especially in genes predicted to
encode proteins exported to the host cell cytoplasm and
the RBC membrane [52,53]. The work shown here
extends these efforts significantly by focusing on malaria
parasites replicating in vivo, in a more complex setting.
With P. yoelii 17X blood-stage parasites, global gene ex-
pression profiles were remarkably consistent even in the
presence of a changing host environment.
Initially, three genetically identical, age-matched
BALB/cByJ mice were infected with the same inoculum
of P. yoelii 17X iRBCs obtained from a donor mouse. P.
yoelii RNA was isolated from each animal after a 10–
11 day period of replication in vivo. As the in vivo envir-
onment is expected to be comparable in this setting,
only a small set of differentially expressed genes was
anticipated. Parasite gene expression patterns in each of
the three animals were virtually identical with only five
to six differentially expressed genes. Between the initi-
ation of infection and harvest of iRBCs for RNA isola-
tion, P. yoelii parasites in this study completed 10–12
replication cycles in vivo. Over this time, the number of
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somewhat relative to the population of P. yoelii iRBCs
used to initiate the infection. This was the case, but the
increase was relatively small involving only 40–60 genes
out of the set represented by ~ 6,700 oligonucleotides on
the arrays. A small cluster of genes expressed in late-
stage parasites and potentially involved in merozoite in-
vasion of host cells were differentially expressed between
the donor mouse and recipients. This may not be sur-
prising as iRBCs were harvested early during ascending
parasitaemia when P. yoelii 17X parasites can be found
in varying degrees in both normocytes and reticulocytes.
This change in gene expression may reflect utilization of
multiple invasion pathways. Finally, a number of poten-
tially influencing variables were further increased by com-
paring gene expression profiles of P. yoelii 17X blood-stage
parasites harvested from four independent infections
initiated with iRBCs obtained from separate donor mice.
Remarkably, the number of differentially expressed genes
in pair-wise comparisons remained low (10–50 genes).
These represent genes that are involved in diverse or un-
known functions and at present, the associated changes do
not appear to reflect a biologically significant response to
the host environment. This, combined with a false discov-
ery rate of 1% associated with this analysis suggest that de-
tection of a low number of differentially expressed but
largely unrelated genes could simply represent ‘noise’ in-
herent to large microarray analysis.
Non-lethal P. yoelii 17X parasites replicate preferen-
tially in reticulocytes but do invade and develop within
mature RBCs when reticulocytes are limiting. Parasites
harvested on day 10 of P. yoelii 17X infection will be
present in both reticulocytes and normocytes. As a result
of an influx of new reticulocytes into circulation, P. yoelii
17X parasites will be found almost exclusively in reticu-
locytes by day 14 post-infection. As such, substantial dif-
ferences in patterns of P. yoelii 17X gene expression in
parasites harvested on day 10 versus day 14 were
expected. In addition to the shift in host cell tropism,
the ongoing infection increases parasite burden, host
stress and immune pressure that could also influence P.
yoelii 17X expression profiles. While the number of dif-
ferentially expressed genes in this comparison increased
to 95, these were not clustered based on related function
or biological process and the majority were of unknown
function. In an early study, utilizing lethal P. yoelii 17XL
parasites, a similar number of genes altered in associ-
ation with a shift in host cell preference from normo-
cytes to reticulocytes were identified [54]. The function
of these genes will be revisited as the annotation of both
P. falciparum and P. yoelii genomes progresses. To fur-
ther examine the role of host cell availability and immune
pressure, gene expression in parasites isolated on day 10
and day 18 of infection was compared. Parasitaemia atthese two time points is comparable. However on day 18,
70-75% of RBCs in circulation are reticulocytes and P. yoe-
lii iRBCs are rapidly being cleared from circulation by
immune-mediated mechanisms. Nearly 200 genes were
differentially expressed in P. yoelii iRBCs on day 18 rela-
tive to day 10 of infection; the largest set in this study. On
day 18, several genes encoding components of the cyto-
plasmic translation machinery were down-regulated while
a second set associated with merozoite invasion were up-
regulated. In P. falciparum, transcription of genes encod-
ing the cytoplasmic translation machinery generally peaks
in ring-stage parasites at ~12 hours post-invasion, fol-
lowed by a marked down-regulation in trophozoite-
and schizont-stage parasites. In contrast, transcription
of genes involved in schizont rupture and merozoite in-
vasion is relatively low through most of the asexual
cycle, peaking at ~42 hours post-invasion [4,5]. Differ-
ences noted in gene expression in P. yoelii parasites on
day 18 versus day 10 of infection may partially be
explained by a modest shift noted in distribution of
parasite stages in circulation toward increased schi-
zonts and decreased trophozoites. It is also clear that
infected blood isolated on day 18 contains damaged
host cells and dying parasites, as well as free extracellu-
lar parasites. These factors likely contributed to a
mixed alteration in expression profiles at this late time
point during infection.
To focus on the role of the host immune response on
parasite gene expression, two approaches to actively alter
host immune pressure were taken. In the first approach,
all antibody mediated immune pressure was removed by
infecting B cell deficient JHD mice. It was expected that
in the absence of antibodies, P. yoelii growth would be
unchecked with an increase in the diversity of parasite
populations and gene expression profiles. This did not
occur as only seven genes were differentially expressed
when P. yoelii parasites isolated from B cell deficient
JHD mice were compared with those from immunocom-
petent control mice. In the second approach, immune
pressure on P. yoelii 17X parasites was increased by im-
munizing mice with a preparation of parasite proteins
associated with the membrane of infected reticulocytes.
Here, immunization-induced antibodies were expected
to select for the growth of parasites with altered gene ex-
pression patterns that included changes in members of
the yir and pyst-a multigene families that encode pro-
teins localized to the erythrocyte membrane. Unexpect-
edly, this did not occur as only 10 genes were
differentially expressed. Even in these situations where
the host immune response was experimentally manipu-
lated, P. yoelii 17X gene expression proceeded unaltered.
This is very reminiscent of the ‘hard-wired’ programme
of gene expression observed with in vitro cultures of P.
falciparum [4,5,46].
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sion, the expression of members of two multi-gene families
in P. yoelii, the yir and pyst-a were of particular interest.
Previous studies have shown that at a population level,
many yir genes are transcribed during blood-stage infec-
tion, in a seemingly random order. Transcription at the
level of individual parasites appears to be tightly controlled,
with each parasite transcribing between one and three yir
genes [55]. In the present study, significant differences in
the expression of yir family members across experimental
conditions were not observed, including the comparison of
P. yoelii 17X day 10 and day 18 parasites. This is in agree-
ment with the study by Cunningham et al. examining the
expression of a subset of the yir repertoire on days 12 and
18 post-infection [20]. Of note, expression of a fairly large
number of the yir genes (89–155) was consistently
observed using signal intensity greater than the 50th per-
centile on each array as a benchmark. These expressed yir
genes were distributed across five previously reported
phylogenetic groups, with no obvious bias toward any one
group [56].
The expression of pyst-a genes followed a similar pattern
to the yir family, with little to no differential expression be-
tween conditions. It appears that a large proportion of pyst-
a family members are expressed in a mixed blood-stage in-
fection. Whether pyst-a gene expression is more restricted
in individual parasites has not been determined. No yir or
pyst-a members were differentially expressed in wild-type
versus JHD animals, in agreement with a study examining
expression of a subset of yir members in wild-type versus
Rag2 knockout mice, which lack mature B and T cells [20].
A more extensive analysis of yir and pyst-a expression dur-
ing primary and secondary infections using a microarray
approach would be of interest. It has been suggested that
the polymorphic erythrocyte membrane antigens encoded
by the yir and/or pyst-a multigene families may function as
part of a parasite immune evasion strategy. For immune
evasion, the current data suggest that changing the pattern
of gene expression may be less important than showering
the host immune system with a large repertoire of poly-
morphic antigens at any given time. In fact, prior
immunization of mice with the PyRMP preparation may
have further impeded the development of protective im-
mune responses following challenge infection as these ani-
mals developed a persistent infection which was difficult to
clear. In agreement with the current findings, members of
the cir multi-gene family do not seem to be differentially
expressed during the course of blood-stage P. chabaudi in-
fection, but there is some indication that cir gene expres-
sion varies in parasites localized to different host tissues
[21]. However, it is still possible that much like the P. falcip-
arum EMP1 and the var gene family, the yir and/or pyst-a
encoded proteins may possess specific functions required
for parasite growth and development in vivo.Overall, in vivo, P. yoelii 17X gene expression did not
appear to be appreciably influenced by the host environ-
ment. These data in the P. yoelii 17X model differ from
that reported by Daily et al. [7] who detected distinct pat-
terns of gene expression in P. falciparum parasites isolated
from malaria-infected patients. In light of these data,
changes in the expression of genes encoding a set of mito-
chondrial proteins (n= 148), across all experimental con-
ditions was examined. Significant changes that would be
consistent with distinct physiological states or a response
to environmental stress were not observed (Additional file
3). Although parasite gene expression was assessed
in vivo, the P. yoelii model is still less complex than with
P. falciparum infected human subjects. Here, a single
cloned line of P. yoelii 17X that does not produce gameto-
cytes was utilized to simultaneously infect genetically
identical mice housed in environmentally controlled, spe-
cific pathogen free conditions. In some regards, this lack
of gametocyte-stage parasites is advantageous, as detec-
tion of differential gene expression due to varying gameto-
cyte levels across samples can be ruled out. On the other
hand, the repeated passage of this P. yoelii 17X line in the
vertebrate host and/or the lack of exposure to the mos-
quito vector could have altered regulatory mechanisms
that control expression of certain gene subsets (i.e. yir or
pyst-a genes). It is also possible that the greater diversity
in human hosts (genetic, environmental) may have a
greater influence on parasite gene expression than we
observed in the P. yoelii model. Finally, each isolate of P.
falciparum may exhibit unique elements of a ‘hard-wired’
programme of gene expression that can be detected when
comparing isolates obtained from individual malaria
patients. Co-infection of human subjects with such dis-
tinct P. falciparum clones will increase diversity in the
overall P. falciparum gene expression profile detected in a
single host and may allow preferential growth of P. falcip-
arum clones in specific in vivo environments.Conclusions
The present study shows that gene expression patterns
of blood-stage P. yoelii 17X parasites replicating in vivo
are very stable and do not vary appreciably even at
ascending and peak parasitaemia and in the presence or
absence of host immune pressure. These findings sup-
port the notion of a ‘hard wired’ gene expression pattern
in plasmodial species. Additionally, although a relatively
large number of yir and pyst-a are expressed across the
conditions studied here, there was no evidence of signifi-
cant differential expression within these multi-gene fam-
ilies. Concurrent expression of a large number of
polymorphic antigens in blood-stage malaria parasites
may be a strategy to impede the development of protect-
ive immune responses.
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Additional file 1: yir and pyst-a oligonucleotides on Plasmodium
yoelii DNA microarrays that mapped to a single gene. In assessing
the number of yir and pyst-a genes expressed in a given sample, only
data obtained with yir and pyst-a oligos that mapped to a single gene
were considered. Mapping data available on PlasmoDB [3] was used to
focus the analysis on 464/859 yir oligos (top portion of Table) and 74/140
pyst-a oligos (bottom portion of Table) on P. yoelii DNA microarrays.
Additional file 2: Differential gene expression between Plasmodium
yoelii 17X parasites isolated from individual mice. Three animals (M1,
M2 and M3) were infected with P. yoelii 17X iRBCs from a single donor
mouse and gene expression analysed using P. yoelii DNA microarrays. Of
three possible pair-wise comparisons, significant differential gene
expression was only seen between M2 and M3 (black text) and M1
versus M3 (blue text). For each differentially expressed gene, oligo ID and
gene name are listed [3]. Log2 Fold Changes and adjusted p-values are
also included, as are the predicted number of amino acids (AA) and
molecular weight in Daltons (MW). Where available, P. falciparum
orthologs and associated Plasmodb.org accession numbers are included
(Pf Ortholog # and Pf Name). Functional groupings (Category) are listed
at the far right of the Table. For detailed information regarding data
analysis and gene categorization, please see the Methods.
Additional file 3: Comparative expression of Plasmodium yoelii
genes encoding mitochondria associated proteins. Data on the
differential expression of genes encoding mitochondria associated
proteins is shown for all comparisons. The gene set included P. yoelii
orthologs of putative P. falciparum mitochondrial proteins [7,41] Mather
and Vaidya, unpublished data] for which signal intensity across arrays was
consistently above the 50th percentile. Shown are the P. falciparum Gene
ID and Name, P. yoelii Oligo ID and Name and for each comparison, the
corresponding the log2 fold change and adjusted p-value. Log2 fold
change values >1 are shaded in red, log2 fold change values <−1 are
shaded in green and adjusted p-values <0.01 are shaded in yellow.
Additional file 4: Differential gene expression between parasites
isolated from a single donor mouse and three individual animals.
Three animals (M1, M2 and M3) were infected with P. yoelii 17X iRBCs
from a single donor mouse (D) and gene expression analysed using
P. yoelii DNA microarrays. Three pair-wise comparisons were possible:
D versus M1 (black text), D versus M2 (blue text) and D versus M3 (red text).
For differentially expressed genes, oligo ID, gene name, log2 fold change,
adjusted p-value, predicted number of amino acids, predicted MW,
available P. falciparum ortholog information and functional categories are
provided as described for Additional file 2.
Additional file 5: Differential gene expression between Plasmodium
yoelii 17X parasites isolated from independent infections. Groups of
animals were infected on four separate occasions (I1, I2, I3 and I4) using
four separate donor animals and gene expression analysed using P. yoelii
DNA microarrays. Six possible pair-wise comparisons were considered:
I1 versus I2 (black text), I1 versus I3 (blue text), I1 versus I4 (red text), I2
versus I3 (green text), I2 versus I4 (purple text) and I3 versus I4 (blue text).
For differentially expressed genes, oligo ID, gene name, log2 fold change,
adjusted p-value, predicted number of amino acids, predicted MW,
available P. falciparum ortholog information and functional categories are
provided as described for Additional file 2.
Additional file 6: Differential gene expression on days 10/14, 10/18
and in the absence/presence of host antibody responses. Groups of
wild-type animals were infected with P. yoelii 17X iRBCs and parasite
RNA was isolated on day 10 (D10), day 14 (D14) or day 18 (D18)
post-infection. Immunologically intact (WT) and B-cell deficient JHD (JHD)
animals were similarly infected and parasite RNA was isolated on day 10.
A third set of animals was immunized three times with a preparation of
P. yoelii reticulocyte membrane proteins plus Quil A as adjuvant (RMP) or
with Quil A alone (QA) prior to P. yoelii 17X challenge. Parasite RNA was
then isolated on day 10 (QA) or day 12 (RMP) post-infection. Gene
expression was analysed using P. yoelii DNA microarrays and the
following comparisons were made: D10 versus D14 (black text), D10
versus D18 (blue text), WT versus JHD (red text), and QA versus RMP(green text). For differentially expressed genes, oligo ID, name, log2 fold
change, adjusted p-value, predicted number of amino acids, predicted
MW, available P. falciparum ortholog information and functional
categories are provided as described for Additional file 2.
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